Dr Richard Grocott-Mason completed his undergraduate training at Jesus College, Oxford and St Thomas’ Hospital Medical School, London, qualifying in 1986. Following that, he undertook his specialist training in Cardiology and General Medicine at King’s College Hospital, The London Chest Hospital, Guy’s Hospital, Harefield Hospital and the University of Wales College of Medicine, Cardiff.
In 1999, he was appointed as Consultant Cardiologist at Hillingdon Hospital and Harefield Hospital. Shortly after that he was appointed as he Clinical Director for Medicine and then as Joint Medical Director and Responsible Officer for The Hillingdon Hospitals NHS Foundation Trust and in 2014 he was appointed as Director of the Harefield Heart Division. In December 2015 he became the Interim Medical Director & Responsible Officer of the Royal Brompton & Harefield NHS Foundation Trust and was appointed to the permanent post in June 2016.
His vast experience of over 17 years covers specialist interests such as general adult cardiology, including assessment of coronary artery disease, valve disease and heart failure. He has also trained as an interventional cardiologist in coronary angioplasty and is an active member of the primary angioplasty team at Harefield Hospital.
Richard is actively involved in research, having published over 60 papers and case reports over his career on topics ranging from basic science to long-term outcomes from cardiac transplantation and aortic valve replacement. He also holds a passionate interest in delivering clinical service of the highest quality and is always looking for innovative ways to implement and improve clinical services.
MB BS (1986) - University of London
• Grocott-Mason, R.M., Lund, O., Elwidaa, H., Maxhar, R., Chandrasakeran, V., Mitchell, A.G., Ilsley, C., Khaghani, A., Rees, A., and Yacoub, M. Long-term results after aortic valve replacement in patients with congestive heart failure: homografts vs prosthetic valves. Eur. Heart J. Oct;21(20):1698-1707, 2000.
• MacCarthy, P.M., Grocott-Mason, R.M., Prendergast, B., and Shah, A.M. Contrasting inotropic effects of endogenous endothelin in the normal and failing human heart: studies with an intracoronary ET(A) receptor antagonist. Circulation Jan 18;101(2):142-7, 2000.
• Ilsley C, Grocott-Mason R. Setting up a primary percutaneous coronary intervention service – the Harefield experience. Recent advances in Cardiology 2008;15:169-183
• Doyle J, Grocott-Mason R, Hardmand T, Malik O, Dubrey SW. Midodrine: use and current status in the treatment of hypotension. Br J Cardiol. 2012; 19:34-7.